The Latest
-
Last Minute Thought: Buy or Sell IBM Before Earnings?
-
Coronavirus update: AstraZeneca/Oxford vaccine shows promise; spiking cases ramp up fear factor
-
Coronavirus vaccine timeline development is ‘astounding’: Doctor
-
AstraZeneca Vaccine Data Appear Less Competitive, Analysts Say